Relating to: health care costs omnibus, granting rule-making authority, making an appropriation, and providing a penalty. (FE)

SB 50 establishes a Prescription Drug Affordability Review Board to address prescription drug costs, requiring it to meet quarterly and include balanced representation from pharmaceutical manufacturers, health insurers, healthcare providers, and the public. The bill allocates $500,000 annually for state operations related to this board and funds a pilot project to create value-based diabetes medication arrangements with pharmacy benefit managers. It also modifies Medicaid copayment rules to prevent providers from denying care due to inability to pay copays, while creating a new tool for prescribers to disclose drug costs to patients. Additionally, the bill authorizes partnerships with out-of-state drug repositories and allows pharmacists to count free clinic volunteer hours toward continuing education requirements.